CaixaBank, S.A.’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-450
Closed -$17.5K – 329
2016
Q4
$17.5K Buy
+450
New +$18.2K ﹤0.01% 189

Other funds holding PBE

CaixaBank, S.A.'s PBE Position: Q1 2017 in Review

CaixaBank, S.A. sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2017, closing a stake of 450 shares — an estimated $17.5K sold.

CaixaBank, S.A. first reported a position in PBE in Q4 2016 and held it in 1 quarter. The position peaked at $17.5K in Q4 2016. 68 funds tracked by Wall St. Rank hold PBE as of Q1 2017.

  • CaixaBank, S.A. reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2017 after selling out during the quarter.
  • CaixaBank, S.A. sold 450 Invesco Biotechnology & Genome ETF shares in Q1 2017, an estimated $17.5K.
  • CaixaBank, S.A. first reported a position in Invesco Biotechnology & Genome ETF in Q4 2016 and held it in 1 quarter.
  • CaixaBank, S.A.'s Invesco Biotechnology & Genome ETF position peaked at $17.5K in Q4 2016.
  • 68 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2017.

Based on CaixaBank, S.A.'s 13F filing for Q1 2017, filed 16 Nov 2026.